Drugs / LENINGRADO 5 association
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT03814148 | Jun 2019 → Jun 2020 | hypertensive disorder | EMS | Withdrawn | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | LENINGRADO 5 association | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03814148 ↗ |
| Route | Oral | “1 coated sustained-release tablet, oral, once a day.” NCT03814148 ↗ |